Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3334717 | Surgical Pathology Clinics | 2012 | 22 Pages |
Abstract
The purpose of this review is to discuss important molecular changes that aid decision making in patient management and play a role in emerging treatment strategies for gastrointestinal malignancies. Although screening and surveillance practices have had an impact on the natural history of some tumor types, gastric carcinoma is a major cause of morbidity and mortality in high prevalence regions and colorectal carcinoma is still the fourth leading cause of cancer related death in the United States.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Rhonda K. MD, Wade S. MD,